Abstract
The importance of antibodies in providing specific protection against disease has long been recognized. Antibodies can neutralize the effects of bacterial toxins, such as those causing tetanus and diptheria, can facilitate the killing of pathogenic bacteria, and can protect against viral infection of cells. The ability to specifically immunize and provide protection against infectious disease has had a major impact on public health. Indeed a coordinated program of immunization has led to the complete elimination of smallpox. It is perhaps fitting that smallpox should be the first disease to be eradicated in such a manner, because it was Jenner’s work with this disease which can be considered to have been the beginning of modern immunology.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
J. Banerji, L. Olsen, and W. Schaffner, A lymphocyte-specific cellular enhancer is located downstream of the joining region in immunoglobulin heavy chain genes, Cell 33: 729 (1983).
B. K. Birshtein, R. Campbell, and B. Diamond, Effects of immunoglobulin structure on Fc receptor binding: a mouse myeloma variant immunoglobulin with a γ2b- γ2a hybrid heavy chain having complete γ2a Fc region fails to bind to γ2a Fc receptors on mouse macrophages, J. Immunol. 129: 610 (1982).
B. K. Birshtein, R. Campbell, and M. L. Greenberg, A γ2b- γ2a hybrid immunoglobulin heavy chain produced by a variant of the MPC-11 mouse myeloma cell line, Biochemistry 19: 1730 (1980).
H. E. Blythman, P. Casellas, O. Gros, P. Gros, F. K. Jansen, F. Paolucci, B. Pau, and H. Vidal, Immunotoxins. Hybrid molecules of monoclonal antibodies and a toxin subunit specifically kill tumor cells, Nature (London) 290: 145 (1981).
C. Boitard, S. Michie, P. Serrurier, G. W. Butcher, A. P. Larkins, and H. O. McDevitt, In vivo preparation of thyroid and pancreatic auto-immunity in the BB rat by antibody to class II major histocompatibility complex gene products, Proc. Natl. Acad. Sci. U.S.A. 82:6627 (1985).
G. L. Boulianne, N. Hozumi, and M. J. Shuman, Production of functional chimeric mouse/human antibody, Nature (London) 312: 643 (1984).
G. Chu and P. A. Sharp, SV40 DNA transfection of cells in suspension: analysis of the efficiency of transcription and translation of T-antigen, Gene 13: 197 (1981).
W. D. Cook, S. Rudikoff, A. M. Giusti, and M. D. Scharff, Somatic mutation in a cultured mouse myeloma cell affects antigen binding, Proc. Natl. Acad. Sci. U.S.A. 79: 1240 (1982).
W. D. Cook and M. D. Scharff, Antigen binding mutants of mouse myeloma cells, Proc. Natl. Acad. Sci. U.S.A. 74: 5687 (1977).
J. Davies and A. Jiminez, A new selective agent for eukaryotic cloning vectors, Am. J. Trop. Med. Hyg. 29 (5): 1089 (1980).
J. Davies and D. I. Smith, Plasmid determined resistance to anti-microbial agents, Ann. Rev. Microbiol. 32: 469 (1978).
B. Diamond, B. K. Birshtein, and M. D. Scharff, Site of binding of mouse IgG2b, to the Fc receptor on mouse macrophages, J. Exp. Med. 150: 721 (1979).
L. Emorine, M. Kuehl, L. Weir, P. Leder, and E. E. Max, A conserved sequence in the immunoglobulin JK-CK intron: possible enhancer element, Nature (London) 309: 447 (1983).
T. J. Franklin and J. M. Cook, The inhibition of nucleic acid synthesis by mycophenolic acid, Blochem. J. 113: 515 (1969).
S. D. Gillies, S. L. Morrison, V. T. Oi, and S. Tonegawa, A tissue specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene, Cell 33: 717 (1983).
D. G. Gilliland, Z. Steplewski, R. J. Collier, K. F. Mitchell, T. H. Chang, and H. Koprowski, Antibody-directed cytotoxic agents use of monoclonal antibody to direct the action of toxin A chains to colorectal carcinoma cells, Proc. Natl. Acad. Sci. U.S.A. 77: 4539 (1980).
F. L. Graham and A. J. van der Eb, A new technique for the assay of infectivity of human adenovirus 5 DNA, Virology 52: 456 (1973).
P. D. Gregor and S. L. Morrison, A myeloma mutant with a novel 31 flanking region: loss of normal sequence and insertion of repetitive elements leads to decreased transcription but normal processing of the alpha heavy chain gene products, Mol. Cell. Biol, in press (1986).
M. Heidelberger and F. F,. Kendall, A quantitative theory of the precipitin reaction. III. The reaction between crystalline egg albumin and its homologous antibody, J. Exp. Med. 62: 697 (1935).
B. J. Kobrin, C. K. Milcarek, and S. L. Morrison, Sequences near the 3’ secretion-specific polyadenylation site influence the levels of secretion-specific and membrane-specific IgG2b, mRNA in myeloma cells, Mol. Cell. Biol, in press (1986).
G. Köhler and C. Milstein, Continuous cultures of fused cells secreting antibody of predefined specificity, Nature (London) 256: 495 (1975).
K. A. Krolick, C. Villemez, P. Isahson, J. W. Uhr, and E. S. Vitetta, Selective killing of normal or neoplastic B cells by antibodies coupled to the A chain of ricin, Proc. Natl. Acad. Sci. U.S.A. 77: 5419 (1980).
S. Larson, Radiolabeled monoclonal anti-tumor antibodies in diagnosis and therapy, J. Nucl. Med. 26: 538 (1985).
R. Levy and R. A. Miller, Biological and clinical implications of lymphocyte hybridomas: tumor therapy with monoclonal antibodies, Ann. Rev. Med. 34: 107 (1983).
B. Liesegant, A. Radbruch, and K. Rajewsky, Isolation of myeloma variants with predefined variant surface immunoglobulin by cell sorting, Proc. Natl. Acad. Sci. U.S.A. 75: 3901 (1978).
S. L. Morrison, Transfectomas provide novel chimeric antibodies, Science 229: 1202 (1985).
S. L. Morrison, M. J. Johnson, L. A. Herzenberg, and V. T. Oi, Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains, Proc. Natl. Acad. Sci. U.S.A. 81: 6851 (1984).
S. L. Morrison, L. A. Wims, and V. T. Oi, Transfectomas: a new approach for the production of monoclonal antibodies, in: “Monoclonal Anti-bodies T84: Biological and Clinical Applications,” A. Pinchera, G. Doria, F. Dammacco and A. Bargellesi, eds., Editrice Kurtis, Milano, Italy (1985).
R. C. Mulligan and P. Berg, Expression of a bacterial gene in mammalian cells, Science 209: 1422 (1980).
R. C. Mulligan and P. Berg, Selection for animal cells that express Escherichia coli gene coding for xanthine-guanine phosphoribosyl- transferase, Proc. Natl. Acad. Sci. U.S.A. 78: 2072 (1981).
M. S. Neuberger, G. T. Williams, and R. O. Fox, Recombinant antibodies possessing novel function, Nature (London) 312: 604 (1984).
M. Nose and H. Wigzell, Biological significance of carbohydrate chains on monoclonal antibodies, Proc. Natl. Acad. Sci. U.S.A. 80: 6632 (1983).
A. Ochi, R. G. Hawley, T. Hawley, M. J. Shulman, A. Traunecker, G. Kohler, and N. Hozumi, Functional immunoglobulin M production after transfection of cloned immunoglobulin heavy and light chain genes in lymphoid cells, Proc. Natl. Acad. Sci. U.S.A. 80: 6351 (1983).
V. T. Oi, S. L. Morrison, L. A. Herzenberg, and P. Berg, Immunoglobulin gene expression in transformed lymphoid cells, Proc. Natl. Acad. Sci. U.S.A. 80: 825 (1983).
D. Picard and W. Schaffner, A lymphocyte-specific enhancer in the mouse kappa gene, Nature (London) 307: 80 (1984).
H. Potter, L. Weir, and P. Leder, Enhancer-dependent expression of human kappa immunoglobulin genes introduced into mouse pre-3 lymphocytes by electroporation, Proc. Natl. Acad. Sci. U.S.A. 81: 7161 (1984).
J.-L. Preud’homme, B. K. Birshtein, and M. D. Scharff, Variants of a mouse myeloma cell line that synthesize immunoglobulin heavy chains having an altered serotype, Proc. Natl. Acad. Sci. U.S.A. 72: 1427 (1975).
C. Queen and D. Baltimore, Immunoglobulin gene transcription is activated by downstream sequence elements, Cell 33: 741 (1983).
D. Rice and D. Baltimore, Immunoglobulin gene transcription is activated by downstream sequence elements, Proc. Natl. Acad. Sci. U.S.A. 79: 7862 (1982).
R. M. Sandri-Goldin, A. L. Goldin, M. Levine, and J. C. Glorioso, High-frequency transfer of cloned herpes simplex virus type 1 sequences to mammalian cells by protoplast fusion, Mol. Cell Biol. 1: 743 (1981).
J. Sharon, M. L. Gefter, T. Manser, S. L. Morrison, V. T. Oi, and M. Ptashne, Expression of a VHCk chimeric protein in mouse myeloma cells, Nature (London) 309: 364 (1984).
P. J. Southern and P. Berg, Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter, J. Molec. Appl. Genet. 1: 327 (1982).
L. K. Tan, V. T. Oi, and S. L. Morrison, A human-mouse chimeric immune globulin gene with a human variable region is expressed in mouse myeloma cells, J. Immunol. 135: 3564 (1985).
S. A. Tilley, L. A. Eckhardt, K. B. Marcu, and B. K. Birshtein, Hybrid γ2b- γ2a genes expressed in myeloma variants: evidence for homologous recombination, Proc. Natl. Acad. Sci. U.S.A. 80: 6967 (1983).
E. S. Vitetta, K. A. Krolick, M. Miyama-Inaba, W. Cushley, and J. W. Uhr, Immunotoxins: a new approach to cancer therapy, Science 219: 644 (1983).
M. K. Waldor, S. Sriram, R. Hardy, L. A. Herzenberg, L. Lanier, M. Lim, and L. Steinman, Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T cell subset marker, Science 227: 415 (1985).
R. Wall and M. Kuehl, Biosynthesis and regulation of immunoglobulins, Ann. Rev. Immunol. 1: 393 (1983).
M. Wigler, S. Silverstein, L.-S. Lee, A. Pellicer, Y. C. Cheng, and R. Axel, Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells, Cell 11: 223 (1977).
D. M. Zaller and L. A. Eckhardt, Deletion of a B cell specific enhancer affects transfected, but not endogenous immunoglobulin heavy chain gene expression, Proc. Natl. Acad. Sci. U.S.A. 82: 5088 (1985).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Plenum Press, New York
About this chapter
Cite this chapter
Morrison, S.L., Wims, L.A., Gregor, P.D., Kobrin, B.J., Oi, V.T. (1987). Transfectomas Provide Antibodies with Novel Structures and Functions. In: Szentivanyi, A., Maurer, P.H., Janicki, B.W. (eds) Antibodies. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1873-6_14
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1873-6_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9044-5
Online ISBN: 978-1-4613-1873-6
eBook Packages: Springer Book Archive